Mild phenotype in Pelizaeus-Merzbacher disease caused by a PLP1-specific mutation
| Autor: | Hitoshi Osaka, Shiro Koizume, Seiji Kimura, Hiroko Iwamoto, Haruhiko Aoyama, Jun-ichi Nagai, Kenji Kurosawa, Sumimasa Yamashita |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Adult
Male Models Molecular Gene isoform Proteolipid protein 1 Pelizaeus-Merzbacher Disease Mild phenotype Mutant Biology Truncate Exon Developmental Neuroscience medicine Humans Myelin Proteolipid Protein Gene Genetics Pelizaeus–Merzbacher disease Sequence Analysis DNA General Medicine medicine.disease Magnetic Resonance Imaging Molecular biology Phenotype Mutation Pediatrics Perinatology and Child Health Neurology (clinical) |
| Zdroj: | Brain and Development. 32:703-707 |
| ISSN: | 0387-7604 |
| DOI: | 10.1016/j.braindev.2009.11.004 |
| Popis: | We present the case of a 26 year-old man who developed normally until he began having difficulty walking at age 12. He subsequently became unable to stand at 15 years old and exhibited mental regression and generalized tonic convulsions by age 20. Magnetic resonance imaging revealed incomplete myelination of cerebral white matter, which resembled that of Pelizaeus-Merzbacher disease. By sequencing the proteolipid protein 1 (PLP1) gene, we found a novel mutation (c.352_353delAG (p.Gly130fs)) in the latter half of exon 3 (exon 3B) that is spliced out in the DM20 isoform. Exon 3B mutations are known to cause a mild phenotype since they do not disturb DM20 production. Mutations that truncate PLP1 correlate with a mild phenotype by activating the nonsense-mediated decay mechanism that specifically detects and degrades mRNAs containing a premature termination codon. This attenuates the production of toxic mutant PLP1. The very mild presentation in the present case seems to be derived from the unique nature of the mutation, which preserves DM20 production and decreases mutant PLP1. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect